Literature DB >> 22507678

Clinical observation of fetal olfactory ensheathing glia transplantation (OEGT) in patients with complete chronic spinal cord injury.

Jun Wu1, Tiansheng Sun, Chaoqun Ye, Jianhua Yao, Bing Zhu, Hongying He.   

Abstract

This study was designed to observe the functional changes after fetal olfactory ensheathing glia transplantation (OEGT) into the spinal cord of patients with chronic spinal cord injury (SCI). Patients whose recovery had plateaued for longer than 6 months were enrolled. Six thoracic patients were tested for safety and five cervical patients for efficacy. OEGT was performed according to the method developed by Huang. Average follow-up was 14 months (range 1.0-1.5 years). Sensation improved moderately (light touch 14.2, pin prick 13.6); as did spasticity (1-2 modified Ashworth scale down). Locomotion recovery was minimal (1.6). Useful reticular formation functions were observed, but due to a lack of appropriate outcome measure, they were not recorded and reported.

Entities:  

Mesh:

Year:  2012        PMID: 22507678     DOI: 10.3727/096368912X633743

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  10 in total

Review 1.  Fetal stem cell transplantation: Past, present, and future.

Authors:  Tetsuya Ishii; Koji Eto
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

2.  Recovering Voiding and Sex Function in a Patient with Chronic Complete Spinal Cord Injury by Olfactory Ensheathing Cell Transplantation.

Authors:  Di Chen; Haitao Xi; Ke Tan; Hongyun Huang
Journal:  Case Rep Neurol Med       Date:  2022-07-06

Review 3.  Are Cell-Based Therapies Safe and Effective in the Treatment of Neurodegenerative Diseases? A Systematic Review with Meta-Analysis.

Authors:  Jasper Van den Bos; Yousra El Ouaamari; Kristien Wouters; Nathalie Cools; Inez Wens
Journal:  Biomolecules       Date:  2022-02-21

Review 4.  Progress in stem cell therapy for major human neurological disorders.

Authors:  P L Martínez-Morales; A Revilla; I Ocaña; C González; P Sainz; D McGuire; I Liste
Journal:  Stem Cell Rev Rep       Date:  2013-10       Impact factor: 5.739

Review 5.  Effects of transplantation of olfactory ensheathing cells in chronic spinal cord injury: a systematic review and meta-analysis.

Authors:  Lei Li; Hafeez Adnan; Benchen Xu; Jianmin Wang; Chengke Wang; Fang Li; Kai Tang
Journal:  Eur Spine J       Date:  2014-07-08       Impact factor: 3.134

Review 6.  Therapeutic Potential of Olfactory Ensheathing Cells and Mesenchymal Stem Cells in Spinal Cord Injuries.

Authors:  Zadroga Anna; Jezierska-Woźniak Katarzyna; Czarzasta Joanna; Monika Barczewska; Wojtkiewicz Joanna; Maksymowicz Wojciech
Journal:  Stem Cells Int       Date:  2017-02-16       Impact factor: 5.443

7.  Survival and Integration of Transplanted Olfactory Ensheathing Cells are Crucial for Spinal Cord Injury Repair: Insights from the Last 10 Years of Animal Model Studies.

Authors:  Ronak Reshamwala; Megha Shah; James St John; Jenny Ekberg
Journal:  Cell Transplant       Date:  2019-11-15       Impact factor: 4.064

8.  Comparing the Efficacy and Safety of Cell Transplantation for Spinal Cord Injury: A Systematic Review and Bayesian Network Meta-Analysis.

Authors:  Xiongjie Xu; Zeyan Liang; Yike Lin; Jian Rao; Fabin Lin; Zhelun Yang; Rui Wang; Chunmei Chen
Journal:  Front Cell Neurosci       Date:  2022-04-04       Impact factor: 6.147

Review 9.  Progress in clinical trials of cell transplantation for the treatment of spinal cord injury: how many questions remain unanswered?

Authors:  Xu-Chang Hu; Yu-Bao Lu; Yong-Na Yang; Xue-Wen Kang; Yong-Gang Wang; Bing Ma; Shuai Xing
Journal:  Neural Regen Res       Date:  2021-03       Impact factor: 5.135

10.  Human Olfactory Mesenchymal Stem Cells Are a Novel Candidate for Neurological Autoimmune Disease.

Authors:  Chongjun Xiao; Di Lu; Jinshuo Chen; Xiaoyan Chen; Huizhu Lin; Mudan Huang; Shimei Cheng; Yuge Wang; Qiuli Liu; Haiqing Zheng
Journal:  Front Pharmacol       Date:  2021-12-10       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.